Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Healthpeak Properties
DOC
$14.2B
| $19.1M | 0.02% |
598,800
-1,466,131
| -71% | -$46.5M |
|
|
ZIXI
877
DELISTED
Zix Corporation
ZIXI
| $19.1M | 0.02% |
3,361,800
-6,090
| -0.2% | -$34.2K |
|
878
Dell
DELL
$320B
| $19.1M | 0.02% |
1,111,730
-1,260,318
| -53% | -$23.1M |
|
879
Berkshire Hathaway Class B
BRK.B
$1.09T
| $19M | 0.02% |
112,400
-239,000
| -68% | -$39.8M |
|
880
Photronics
PLAB
$1.97B
| $19M | 0.02% |
2,023,000
+23,200
| +1% | +$245K |
|
881
Qorvo
QRVO
$8.67B
| $19M | 0.02% |
+299,906
| New | +$21.4M |
|
882
AGCO
AGCO
$7.11B
| $19M | 0.02% |
281,600
-30,200
| -10% | -$1.93M |
|
883
IDT Corp
IDT
$1.63B
| $18.9M | 0.02% |
1,558,109
-105,080
| -6% | -$1.36M |
|
884
Cohen & Steers
CNS
$4.36B
| $18.9M | 0.02% |
467,200
+11,900
| +3% | +$474K |
|
885
TE Connectivity
TEL
$62B
| $18.9M | 0.02% |
240,600
+192,300
| +398% | +$14.7M |
|
886
Ducommun
DCO
$3.04B
| $18.9M | 0.02% |
597,500
+64,400
| +12% | +$2M |
|
|
SNOW
887
DELISTED
Intrawest Resorts Holdings, Inc.
SNOW
| $18.9M | 0.02% |
794,169
-797,100
| -50% | -$18.9M |
|
888
McGrath RentCorp
MGRC
$2.94B
| $18.8M | 0.02% |
544,202
-27,393
| -5% | -$936K |
|
889
Deere & Co
DE
$167B
| $18.8M | 0.02% |
152,400
+123,700
| +431% | +$14.5M |
|
890
Bank OZK
OZK
$5.69B
| $18.8M | 0.02% |
400,697
-17,500
| -4% | -$832K |
|
891
Wendy's
WEN
$1.65B
| $18.7M | 0.02% |
1,208,522
+817,040
| +209% | +$12.4M |
|
|
TECD
892
DELISTED
Tech Data Corp
TECD
| $18.7M | 0.02% |
184,842
+161,800
| +702% | +$15.6M |
|
893
Planet Fitness
PLNT
$3.65B
| $18.7M | 0.02% |
799,306
+55,288
| +7% | +$1.16M |
|
|
PACW
894
DELISTED
PacWest Bancorp
PACW
| $18.6M | 0.02% |
398,953
-26,700
| -6% | -$1.3M |
|
|
ACTA
895
DELISTED
Actua Corp
ACTA
| $18.6M | 0.02% |
1,325,719
+661,800
| +100% | +$9.32M |
|
|
SJR
896
DELISTED
Shaw Communications Inc.
SJR
| $18.5M | 0.02% |
847,600
-714,800
| -46% | -$15.4M |
|
897
Rexford Industrial Realty
REXR
$8.11B
| $18.5M | 0.02% |
673,300
+442,600
| +192% | +$11.5M |
|
|
MORE
898
DELISTED
Monogram Residential Trust, Inc.
MORE
| $18.5M | 0.02% |
1,901,200
+497,500
| +35% | +$4.94M |
|
899
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.2B
| $18.4M | 0.02% |
841,700
+417,700
| +99% | +$10.1M |
|
900
Lincoln Electric
LECO
$15.6B
| $18.4M | 0.02% |
+199,838
| New | +$18M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.